Huntsman Q2 2026: Revenue Climbs 14%, Net Loss Narrows; Merger with Olin on Track
HUN sits 35% above its 52-week low of $7.295.
Summary
Huntsman delivered improved Q2 2026 results, with revenue up 14% and a sharply narrower net loss, while advancing its planned merger with Olin Corporation.
Key Events · Earnings and Guidance · HUN
-
Revenue Rises 14%
Driven by higher average selling prices and volumes across all segments, Q2 2026 revenues reached $1.66 billion, up from $1.46 billion a year ago.
-
Net Loss Narrows Sharply
The net loss attributable to Huntsman Corporation shrank to $6 million, or $0.03 per share, from a loss of $158 million, or $0.92 per share, in Q2 2025.
-
Adjusted EBITDA More Than Doubles
Adjusted EBITDA rose to $120 million from $74 million, with gains posted by all three segments—Polyurethanes, Performance Products, and Advanced Materials.
-
Gomet Business Sale Completed
Closing on June 5, 2026, the sale of the Gomet automotive components business generated approximately $50 million in proceeds and a $22 million gain.
Analysis · HUN · Industrial Applications And Services
A sharp operational rebound marks Huntsman's Q2 2026, with revenues climbing 14% to $1.66 billion and adjusted EBITDA more than doubling to $120 million. The net loss attributable to Huntsman Corporation narrowed dramatically to $6 million from $158 million a year ago, fueled by higher selling prices and volumes across all segments. The quarter also featured a $22 million gain from the sale of the Gomet business. Against this backdrop of recovery, the company is advancing an all-stock merger of equals with Olin Corporation, announced in June, which would forge a $12.5 billion chemicals giant. The deal is expected to close in the first half of 2027, pending shareholder and regulatory approvals. Reflecting a focus on balance sheet strength ahead of the merger, the dividend was cut to $0.0875 per share from $0.25.
At the time of this filing, HUN was trading at $9.82 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $7.30 to $16.09. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.